CANJA Audio Culture’s Post

#Videofriday #17 Every "Congratulations" message has an impact on us. Some are from Portuguese partners, some from historical partnerships (or recent ones), and others from the other side of the world. Just like the one we show you today, from Wonbum Lee, CEO of Whan In Pharma. Partners with whom we hope to walk side by side for many years. Thank you, again, for your words. You might ask, what are we proud of? Well, you can look it up here: https://bial100years.com #BIAL #BIALKeepingLifeinMind #InspiredByTheFuture

Congratulations to Dr. J. Jean Cui! With #lorlatinib's PFS reached more than 60 months (the PFS not reached yet, some estimated it could reach 10 years or more) and #repotrectinib's PFS reached 35.7 months, Jean's creativity (she designed both of the two FDA approved #oncology drugs) is helping transform deadly late-stage #cancer into manageable disease for ALK and ROS1 positive #NSCLC. More to come! https://lnkd.in/g4pSvZyC

Check out this webinar with Chris Dokomajilar on January 16th to see what the year may look like for biopharma dealmaking in 2024! #venturecapital #biotech #biopharma #pharma #dealmaking #2024predictions

I attended the <BIO KOREA 2024> event held at Coex Exhibition Center in Seoul. While the number of attendees hasn't fully recovered to pre-COVID-19 pandemic levels, qualitatively, it was impressive to see the participation of top-notch companies and partners from around the globe. I had pleasant conversations with various #CDMO companies from the United States, Europe, and Asia. Of course, I also exchanged warm greetings with Korean companies. I extend my gratitude to everyone who kindly exchanged business cards with warm greetings. Customers showed a high interest in Quascenta Pte. Ltd.'s offerings like eLogbook, eProcess Pro, and eResidue Pro, which aim to enhance the quality of processes. I believe this warm interest stems from the admirable sense of purpose among CDMO companies striving to deliver better quality to their customers. Personally, rather than solely aiming for sales achievements, I too aspire to take a deeper interest in Quascenta's mission to contribute to the pharmaceutical industry. I respect Ravi Moorthy, the leader of Quascenta, because he believes in integrating our software, knowledge, and experience to deliver more value to customers. #전자로그북 #eLogbook #DataIntegrity #PharmaDigitalization #We_Consider #Quality #Quascenta

Once again the Pharma Supply Chain Leaders Network gathered together to share experiences, learn from each other. After an interesting session on the specifics of clinical supply chains animated by Philippe Chevallier, CEO of N-Side at the end of November, it was now the time for Bram Desmet (prof. Vlerick School / CEO Solventure) to take us along his most recent findings. How to integrate sustainability and human aspects in the business and supply chain strategies? How to make your supply chain more robust and resilient? How to translate your business archetype in a concrete supply chain design.µ? Very interesting exchanges among key players in the Pharma world (Pfizer, J&J, Curium, UCB, Corden, Galapagos, ...) ... and concluded with a nice dinner at the new Living Tomorrow site.

Supply chains are changing ... we need to be more sustainable, in an increasingly volatile environment. With this group of pharma supply chain leaders I explored how to build more sustainable and resilient supply chains. I introduced the need for an S&OP 2.0, that I call Integrated Value Planning, better connected with the supply chain eco-system, and integrating sustainability in the heart of our decision making. More about it in my new book called “ReThinking Supply Chain”. Thank you Alain DOMMISSE for having me for this premiere! #supplychain #pharma

Thrilled to attend #DIAEurope2024, where industry leaders converged to explore cutting-edge advancements in healthcare. From insightful discussions to impactful networking, the conference provided an invaluable platform to delve into the future of pharmaceuticals and regulatory affairs. Grateful for the enriching experiences and connections made! #HealthcareInnovation #Regulatory #clinicalresearch #clinicaltrial #gcp #pharmacovigilance #drugdiscovery #drugdevelopment #drugsafety

📅 Don't miss out! 25th January LinkedIn Live starring Sam Herbert (previously President of World Courier and COO of Clinigen) and Philip Ashton (CEO 7bridges). 🖱️Join us to find out the Pharma trends you can't ignore in 2024! #linkedlive #transportandlogistics #pharmaceuticalindustry

Some interesting insights from the Q&A with Ken Song regarding RayzeBio's journey: 1. Quick Rise to Acquisition: RayzeBio swiftly progressed from Series A to acquisition within a remarkably short timeframe, showcasing effective strategic decision-making and capital deployment. 🚀 2. Navigating Funding Challenges: Despite facing a challenging fundraising environment, RayzeBio demonstrated resilience and strategic foresight by prioritizing proper capitalization over short-term concerns about dilution. 💡 Maintaining Discipline: Throughout the IPO process, RayzeBio remained disciplined, resisting the temptation to maximize gains and ensuring a successful debut on the stock market. 📉 3. Post-IPO Interest and Acquisition: Interestingly, RayzeBio garnered substantial acquisition interest only after going public, indicating that the IPO served as a catalyst for attracting strategic partners. 🔄 4. Future of Radiopharmaceuticals: Song envisions radiopharmaceuticals evolving into a major modality, with increased commitment from pharmaceutical companies and advancements in isotope availability driving further innovation. 🧪 RayzeBio's journey offers valuable insights into biotech entrepreneurship, strategic decision-making, and the evolving landscape of pharmaceutical innovation. 🌱

📌 While #cGMP plays a crucial role in ensuring drug quality and consistency, many biopharmaceutical developers overlook its early adoption. 🔎 Discover why incorporating cGMP chemicals earlier can minimize risks and accelerate your development milestones. Learn about the seamless transition from research phase to clinical production, the significance of quality supplier relationships, and how planning for compliance standards upfront can save time and resources down the line while ensuring a smooth and successful drug development journey. Learn More: 👉 https://lnkd.in/dihFXtQ7 #Fisherscientificeu #DrugDevelopment #Biopharma #QualityControl